- The Current Status and Future Perspectives of Studies of Cannabinoid Receptor 1 Antagonists as Anti-Obesity Agents
[作者:Lee, HK; Choi, EB; Pak, CS,期刊:Current Topics in Medicinal Chemistry, 页码:482-503 , 文章类型: Review,,卷期:2009年9-6]
- Since the discovery of rimonabant (Acomplia: 1), a large effort has been directed at the discovery of new, potent and selective CB1R antagonists that serve as anti obesity drugs. As a result, a number of compounds reache...
- New Trends in Medicinal Chemistry Approaches to Antiobesity Therapy
[作者:Lee, J; Song, KS; Kang, J; Lee, SH; Lee, J,期刊:Current Topics in Medicinal Chemistry, 页码:564-596 , 文章类型: Review,,卷期:2009年9-6]
- The prevalences of overweightedness and obesity are increasing globally at frightening rates, driven by social and economic changes. Furthermore, obesity is associated with the pathogeneses of major diseases, particularl...
- Anti-obesity Agents: A Focused Review on the Structural Classification of Therapeutic Entities
[作者:Oh, S; Kim, KS; Chung, YS; Shong, M; Park, SB,期刊:Current Topics in Medicinal Chemistry, 页码:466-481 , 文章类型: Review,,卷期:2009年9-6]
- In addition to its enormous impacts on an individual's quality of life, obesity is a daunting health problem in the world today and the increasing rate of obesity is now causing a severe burden on health care systems. Fo...
|